Neuraxis, Inc. (NRXS)
Neuraxis, Inc. (NRXS) is a biotechnology company focused on developing neurotherapeutic products targeting neurological and psychiatric disorders. The company specializes in creating innovative treatments leveraging its expertise in neurostimulation and neurotechnology to address unmet medical needs in neurological conditions.
Company News
NeurAxis, Inc. will report its Q1 2025 financial results on May 12, 2025, before market open, and host a conference call on the same day at 9:00 am ET to review the results.
Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock. Avalo Therapeutics, Inc. (NASDAQ: AVTX) gained 52.6% to $0.1295 after the company agreed to divest AVTX-800 series. Shengfeng Development Limited (NASDAQ: SFWL) rose...